BACKGROUND: Ischemic reperfusion (I/R) injury of the kidney is closely associated with delayed graft function, increased acute rejection, and late allograft dysfunction. Splenectomy reduced hepatic I/R injury by inhibiting leukocyte infiltration in the liver, release of TNF-α, cell apoptosis, and expression of caspase-3. Thus, we investigated the effects of splenectomy on renal I/R injury in the rat. METHODS: Male Wistar rats were assigned to four groups: sham operation (sham group), sham operation+splenectomy (sham+SPLN group), right nephrectomy followed by clamping the left renal pedicle for 30min (I/R 30 group), and I/R 30+splenectomy (I/R 30+SPLN group). Renal function was determined by measuring the concentration of blood urea nitrogen (BUN) and serum creatinine (S-Cr). The serum level of tumor necrosis factor-α (TNF-α) was measured as the marker for inflammation. Left kidneys were obtained 24h after reperfusion. TUNEL assay was assessed for cell apoptosis. Spleens were obtained immediately (0-h group) and 3h after reperfusion (3-h group). The removed spleens were histologically evaluated. RESULTS: The BUN and S-Cr levels were significantly lower in the I/R 30+SPLN group than in the I/R 30 group (p<0.05 for both). Apoptotic cells were significantly lower in the I/R 30+SPLN group than in the I/R 30 group. The serum level of TNF-α, which was increased after I/R, was significantly lower in the I/R 30+SPLN group than in the I/R 30 group (p<0.05). Spleen weights were significantly lower in the 3-h group than in the 0-h group (p<0.05). CONCLUSION: These results suggest that splenectomy reduces renal I/R injury, and this effect may occur by an anti-inflammatory pathway and inhibition of cell apoptosis.
BACKGROUND: Ischemic reperfusion (I/R) injury of the kidney is closely associated with delayed graft function, increased acute rejection, and late allograft dysfunction. Splenectomy reduced hepatic I/R injury by inhibiting leukocyte infiltration in the liver, release of TNF-α, cell apoptosis, and expression of caspase-3. Thus, we investigated the effects of splenectomy on renal I/R injury in the rat. METHODS: Male Wistar rats were assigned to four groups: sham operation (sham group), sham operation+splenectomy (sham+SPLN group), right nephrectomy followed by clamping the left renal pedicle for 30min (I/R 30 group), and I/R 30+splenectomy (I/R 30+SPLN group). Renal function was determined by measuring the concentration of blood ureanitrogen (BUN) and serum creatinine (S-Cr). The serum level of tumor necrosis factor-α (TNF-α) was measured as the marker for inflammation. Left kidneys were obtained 24h after reperfusion. TUNEL assay was assessed for cell apoptosis. Spleens were obtained immediately (0-h group) and 3h after reperfusion (3-h group). The removed spleens were histologically evaluated. RESULTS: The BUN and S-Cr levels were significantly lower in the I/R 30+SPLN group than in the I/R 30 group (p<0.05 for both). Apoptotic cells were significantly lower in the I/R 30+SPLN group than in the I/R 30 group. The serum level of TNF-α, which was increased after I/R, was significantly lower in the I/R 30+SPLN group than in the I/R 30 group (p<0.05). Spleen weights were significantly lower in the 3-h group than in the 0-h group (p<0.05). CONCLUSION: These results suggest that splenectomy reduces renal I/R injury, and this effect may occur by an anti-inflammatory pathway and inhibition of cell apoptosis.
Authors: Joseph C Gigliotti; Liping Huang; Hong Ye; Amandeep Bajwa; Kryt Chattrabhuti; Sangju Lee; Alexander L Klibanov; Kambiz Kalantari; Diane L Rosin; Mark D Okusa Journal: J Am Soc Nephrol Date: 2013-08-01 Impact factor: 10.121
Authors: Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Rita Businaro; Diane E Heck; Jeffrey D Laskin; Debra L Laskin Journal: Ann N Y Acad Sci Date: 2016-06-28 Impact factor: 5.691
Authors: Mili Mandal; Carol R Gardner; Richard Sun; Hyejeong Choi; Sonali Lad; Vladimir Mishin; Jeffrey D Laskin; Debra L Laskin Journal: Toxicol Appl Pharmacol Date: 2016-05-07 Impact factor: 4.219
Authors: Se Hyang Hong; Jin Mo Ku; Hyo In Kim; Tai Young Kim; Hye Sook Seo; Yong Cheol Shin; Seong-Gyu Ko Journal: Front Pharmacol Date: 2019-09-19 Impact factor: 5.810
Authors: Ricardo O S Soares; Daniele M Losada; Maria C Jordani; Paulo Évora; Orlando Castro-E-Silva Journal: Int J Mol Sci Date: 2019-10-11 Impact factor: 5.923
Authors: Michel Paul Johan Teuben; Arne Hollman; Taco Blokhuis; Roman Pfeifer; Roy Spijkerman; Henrik Teuber; Hans-Christoph Pape; Luke Petrus Hendrikus Leenen Journal: Eur J Med Res Date: 2021-03-15 Impact factor: 2.175